Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas.

MLA

Edmonson, J. H., et al. “Comparison of Cyclophosphamide plus Cisplatin versus Hexamethylmelamine, Cyclophosphamide, Doxorubicin, and Cisplatin in Combination as Initial Chemotherapy for Stage III and IV Ovarian Carcinomas.” Cancer Treatment Reports, vol. 69, no. 11, Nov. 1985, pp. 1243–48. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3937598&authtype=sso&custid=ns315887.

APA

Edmonson, J. H., McCormack, G. W., Fleming, T. R., Cullinan, S. A., Krook, J. E., Malkasian, G. D., Podratz, K. C., Mailliard, J. A., Jefferies, J. A., Barlow, J. F., & et. al. (1985). Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas. Cancer Treatment Reports, 69(11), 1243–1248.

Chicago

Edmonson, J H, G W McCormack, T R Fleming, S A Cullinan, J E Krook, G D Malkasian, K C Podratz, et al. 1985. “Comparison of Cyclophosphamide plus Cisplatin versus Hexamethylmelamine, Cyclophosphamide, Doxorubicin, and Cisplatin in Combination as Initial Chemotherapy for Stage III and IV Ovarian Carcinomas.” Cancer Treatment Reports 69 (11): 1243–48. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3937598&authtype=sso&custid=ns315887.